Amneal Pharmaceuticals Inc (AMRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2010 | 12-2009 | 09-2009 | 06-2009 | 03-2009 | |
| Sales | 323,333 | 176,134 | 64,946 | 58,416 | 58,913 |
| Cost of Goods | 79,576 | 88,724 | 28,055 | 27,284 | 26,250 |
| Gross Profit | 243,757 | 87,410 | 36,891 | 31,132 | 32,663 |
| Operating Expenses | 33,354 | 36,005 | 26,783 | 27,429 | 28,778 |
| Operating Income | 210,979 | 52,129 | 10,163 | 3,987 | 4,135 |
| Interest Expense | 46 | -490 | 185 | 256 | 294 |
| Other Income | 64 | 121 | 174 | 310 | 204 |
| Pre-tax Income | 210,997 | 52,740 | 10,152 | 4,041 | 4,045 |
| Income Tax | 79,484 | 14,633 | 3,495 | 1,043 | 1,836 |
| Net Income Continuous | 131,513 | 38,107 | 6,657 | 2,998 | 2,209 |
| Minority Interests | 28 | -37 | -28 | -15 | -10 |
| Net Income | $131,485 | $38,144 | $6,685 | $3,013 | $2,219 |
| EPS Basic Total Ops | 2.16 | 0.63 | 0.11 | 0.05 | 0.04 |
| EPS Basic Continuous Ops | 2.16 | 0.63 | 0.11 | 0.05 | 0.04 |
| EPS Diluted Total Ops | 2.06 | 0.61 | 0.11 | 0.05 | 0.04 |
| EPS Diluted Continuous Ops | 2.06 | 0.61 | 0.11 | 0.05 | 0.04 |
| EBITDA(a) | $218,199 | $50,367 | $28,668 | $13,029 | $14,495 |